Crosscut Videos

Now Playing:

Hidden Barriers: How the demographics of clinical trials can hurt people of color

How the demographics of clinical trials can hurt people of color

Medical research in the U.S. has a dark history, particularly when it comes to the Black community. This has led many in communities of color to distrust the institution of medicine. Across the nation, 60% of Americans as a whole said they will get a COVID-19 vaccine. But, among Black people, that number drops to 42%, compared with 83% of Asians, 63% of Latinx, and 61% of white adults, according to the Pew Research Center. Crosscut investigates what that means for research and treatment, and why representation matters when it comes to clinical studies.

How racism directly threatens our public health

After the resurgence of Black Lives Matter protests in 2020, many declared racism a public health crisis. So what exactly does that mean? Scientists now say that, in addition to socioeconomic factors, the constant stress of racism slowly takes a toll on a cellular level. And that can explain some of the pandemic-related health care disparities in our community.

How the demographics of clinical trials can hurt people of color

Medical research in the U.S. has a dark history, particularly when it comes to the Black community. This has led many in communities of color to distrust the institution of medicine. Across the nation, 60% of Americans as a whole said they will get a COVID-19 vaccine. But, among Black people, that number drops to 42%, compared with 83% of Asians, 63% of Latinx, and 61% of white adults, according to the Pew Research Center. Crosscut investigates what that means for research and treatment, and why representation matters when it comes to clinical studies.